Anti-Ms CD26 Purified

*Niedermeyer J, Kriz M, Hilberg F, Garin-Chesa P, Bamberger U, Lenter MC, Park J, Viertel B, Püschner H, Mauz M, Rettig WJ, Schnapp A: Targeted disruption of mouse fibroblast activation protein. Mol Cell Biol. 2000 Feb;20 (3) :1089-94., URL: http://www.ncbi.nlm.nih.gov/pubmed/10629066 , *James MJ, Belaramani L, Prodromidou K, Datta A, Nourshargh S, Lombardi G, Dyson J, Scott D, Simpson E, Cardozo L, Warrens A, Szydlo RM, Lechler RI, Marelli-Berg FM: Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism. Blood. 2003 Sep 15;102 (6) :2173-9., URL: https://pubmed.ncbi.nlm.nih.gov/12775572/, *Dorrell C, Erker L, Lanxon-Cookson KM, Abraham SL, Victoroff T, Ro S, Canaday PS, Streeter PR, Grompe M: Surface markers for the murine oval cell response. Hepatology. 2008 Oct;48 (4) :1282-91., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=abraham+sl+victoroff+t , *Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, Nielsen PF, Ribel U, Watanabe T, Drucker DJ, Wagtmann N: Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci U S A. 2000 Jun 6;97 (12) :6874-9., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=marguet+d+baggio+l, *Adams S, Miller GT, Jesson MI, Watanabe T, Jones B, Wallner BP: PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. Cancer Res. 2004 Aug 1;64 (15) :5471-80., URL: http://www.ncbi.nlm.nih.gov/pubmed/15289357